Little Green Pharma Ltd (ASX:LGP) CEO Paul Long tells Proactive the company is a global, vertically integrated medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. It has two global production sites for the manufacture of its own-branded and white-label ranges of GMP-grade medicinal cannabis products, with its Danish facility being one of the largest GMP medicinal cannabis production sites in Europe and its Western Australia site, which is an indoor GMP production facility, specialising in premium hand-crafted cannabis strains.
Little Green Pharma focused on European expansion
